Navigation Links
Sanovas CEO Larry Gerrans Featured Speaker at AdvaMed 2011
Date:9/22/2011

SAUSALITO, Calif., Sept. 22, 2011 /PRNewswire/ -- Sanovas Inc., a leading developer of minimally invasive technologies for the diagnosis and treatment of pulmonary disease and lung cancer, today announced that CEO and co-founder Larry Gerrans will speak at AdvaMed 2011, the industry's premier medical technology conference taking place Sept. 26-28, 2011 in Washington, D.C. Mr. Gerrans, an industry veteran, will be participating in an interactive panel addressing the challenges and lessons learned as a CEO in the medical device industry.  

Mr. Gerrans has served in executive leadership and consulting roles in the life sciences at Depuy Orthopedics (Johnson & Johnson), Stryker Corp., Smith & Nephew Corp., and the Sorin Group. He is widely recognized as one of the founders and developers of the Endoscopic Surgical Suite (Endo-Suite) and the Digital Operating Room, today's most technologically advanced operating rooms. Mr. Gerrans pioneered the development of the medical industry's first voice-activation technology for surgical device control in the operating theater. He has led the business and product development of minimally invasive surgical techniques, technologies and implant systems for orthopedics, general surgery, gynecology, ENT, cardiac and urology. Mr. Gerrans has participated in most of the major advances in surgical devices.  

"I have experienced first-hand the challenges of developing and commercializing innovative technologies, managing a start-up enterprise and raising money," said Sanovas CEO Larry Gerrans. "I value the opportunity to share my insights at AdvaMed and to hear the experiences of other entrepreneurs as we grow our companies and create new technologies that will advance healthcare."

The panel "Ask the CEO: Life as an Entrepreneur... and Beyond!" will be moderated by Semprus BioSciences CEO and co-founder David Lucchino. Joining Mr. Gerrans on the panel are Willi
'/>"/>

SOURCE Sanovas Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Larry King to Host 10th Annual American Friends of Rabin Medical Center Broadway on the Hudson Gala
2. AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage
3. ProUroCare Medical Elects Larry W. Getlin as New Director
4. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
5. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
7. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
8. Genasense(R) Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress
9. Genta Clinical Programs Featured at American Society of Hematology Meeting
10. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
11. UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "Global A Dialyzer ... 2014" report to their offering. ... Reprocessor ) Industry Report 2014 is a professional ... the A dialyzer reprocessing machine industry. The ...
(Date:6/1/2015)... SETAUKET, N.Y. , June 1, 2015 /PRNewswire/ ... (NASDAQ: HRTX ) today announced positive, top-line ... study.  MAGIC evaluated the efficacy and safety of ... candidate SUSTOL ® (granisetron injection, extended release) ... intravenous (IV) neurokinin-1 (NK 1 ) receptor antagonist ...
(Date:6/1/2015)... -- Researchers from University Hospitals Case Medical Center Seidman ... Medicine will present data from several new studies, including ... cancer patients with advanced solid tumors and a first-of-its-kind ... (SCLC), at the 51 st American Society for ... . Jennifer Eads , ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3New cancer therapy study results - MAGIC Trial 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 3
... Calif., Nov. 24 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), ... a company overview at Piper Jaffray,s 21st Annual Health Care Conference ... New York Palace Hotel. , A live audio webcast of the ... the Company,s Web site, www.isispharm.com . A replay of ...
... , NEW YORK, Nov. 24 A FOX Thanksgiving Day ... the holidays are a time to be grateful for many developments ... that battle each day as survivors, caregivers, and advocates. The 90 ... cancer survivors Scott Hamilton and Dorothy Hamill and a moving number ...
Cached Medicine Technology:FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 2FOX Thanksgiving Day Special 'Kaleidoscope' Unites Cancer Survivors on Ice and in Song to Celebrate Survivorship 3
(Date:6/2/2015)... Mercy Health (formerly Catholic Health Partners) ... – has devoted the seventh of its monthly Mercy ... prevention. One in five Americans will get skin cancer. ... channel, a Mercy Health expert addresses these skin cancer-related ... of skin cancer? ,     What are the main ...
(Date:6/2/2015)... The Radiosurgery Society® (RSS), a non-profit ... Patient Registry evaluating the treatment patterns and clinical ... treatment of centrally located primary non-small cell lung ... study, published in the May, 2015, issue of ... with 114 centrally located lung tumors who were ...
(Date:6/2/2015)... Dallas, TX (PRWEB) June 02, 2015 FDA ... to qualified Diet Doc patients after a satisfactory doctor consultation. ... on the market for several years and has the longest ... Working to block the enzyme that breaks down fats in ... diverting them through the intestinal system to be excreted through ...
(Date:6/2/2015)... 2015 Thermi, formerly ThermiAesthetics, a ... successfully transitioned into its new company headquarters in ... company’s continued rapid worldwide expansion and houses the ... 25 Thermi employees, including those of the warehousing, ... “As one of the fastest growing aesthetic companies ...
(Date:6/2/2015)... June 02, 2015 While the movie ... of comic books, comic books themselves are stepping into ... Uniting Nations plans to produce educational comics in multiple ... Goals for Sustainable Development - an international effort to ... hunger, health, education, sustainable energy, inequality, climate change and ...
Breaking Medicine News(10 mins):Health News:Video provides helpful information about skin cancer prevention 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 2Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 3Health News:Diet Doc Adds FDA Approved Orlistat to their Medically Supervised Diet Plans, Offering Their Patients another Option for Trimming Fat from the Hard to Reach Areas 4Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3
... High alkaline phosphatase levels boosted mortality 25% in chronic ... High levels of alkaline phosphatase -- a routinely measured ... risk of death among patients receiving dialysis for chronic ... data on almost 74,000 hemodialysis patients during a three-year ...
... researchers say , , THURSDAY, July 31 (HealthDay News) -- ... mechanisms behind a problem that has bedeviled many men, ... , The study identifies a key signaling molecule that ... "These are very complex molecular signals, and the authors ...
... PITTSBURGH, July 31 Mylan Inc. (NYSE: MYL ... preferred stock,issuance, the company has declared its quarterly dividend ... of 6.5% and a liquidation,preference of $1,000.00 per share) ... of record as of August 1, 2008., Mylan ...
... ATRC ), a medical device company and a leader in ... following,investor conferences during August:, -- The BMO Focus on ... the Millennium Broadway Hotel in New York. David J. Drachman, President ... present at 9:00 a.m. Eastern time., ...
... to permit the State of Michigan to spray the ... of this important antibiotic to treat blood infections in ... Infectious Diseases Society of America (IDSA). , The ... of Michigan "emergency" permission to use gentamicin to fight ...
... Mich. Pat Phalin learned she had hearing loss at ... local school. The pupils heard sounds she could not hear. ... pattern in his wife,s family history. Her mother, grandfather and ... Phalins, children had hearing problems before he reached school age. ...
Cached Medicine News:Health News:Bone Disease Test Shows Death Risk for Dialysis Patients 2Health News:Mouse Study Finds Molecule That Tells Hair to Grow 2Health News:AtriCure to Present at the BMO Focus on Healthcare and Canaccord Adams Global Growth Conferences in August 2Health News:Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?' 2Health News:Inherited form of hearing loss stems from gene mutation 2Health News:Inherited form of hearing loss stems from gene mutation 3
Inquire...
...
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein....
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: